20908 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#302Composition and method for vancomycin oral liquid
#303Implantable cellular and biotherapeutic agent delivery canister
#304ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE
#305Composition and method for vancomycin oral liquid
#306Nanosystems comprising silver and antibiotics and their use for the treatment of bacterial infections
#307BIOCOMPATIBLE ORGANOGEL MATRICES FOR INTRAOPERATIVE PREPARATION OF A DRUG DELIVERY DEPOT
#308Composition and method for vancomycin oral liquid
#309Enteric combination therapy
#310PERCUTANEOUS ANTI-MICROBIOTA FORMULATIONS
#311METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION
#312IN-SITU GEL-FORMING DELIVERY SYSTEMS, METHODS AND COMPOSITIONS
#313Composition for the treatment of intracellular bacterial infection
#314Antibiotic solution and method of injection to prevent ophthalmic infections
#315Targeted hydrophobic anti-tumor drug nanoformulation and preparation method thereof
#316Drug combination with antitumor effects
#317Treatment of Staphylococcal and Enterococcal Infections Using Substituted Nitrostyrene Compounds
#318METHODS FOR DETECTING AND TREATING LOW-VIRULENCE INFECTIONS
#319Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
#320Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
#321Treatment of infection
#322Cellulosic polymer nanoparticles and methods of forming them
#323PRE-MIXED, READY TO USE VANCOMYCIN COMPOSITIONS
#324COMPOSITIONS, DEVICES AND METHODS FOR TREATING OBSESSIVE-COMPULSIVE DISORDER
#325Inhalable antimicrobial particles and methods of making the same
#326TOPICAL COMPOSITIONS FOR OPHTHALMIC AND OTIC USE
#327Liposomes for drug delivery and methods for preparation thereof
#328Methods and assays for subtyping clonal complex 8 strains
#329Combination treatment of bacterial infection
#330Lipo-glycopeptide cleavable derivatives and uses thereof
#331DRY POWDER VANCOMYCIN COMPOSITIONS AND ASSOCIATED METHODS
#332PHARMACEUTICAL COMPOSITIONS COMPRISING GELS AND METHODS FOR FABRICATING THEREOF
#333NOVEL PARASITE THERAPY
#334BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES
#335Compositions and methods for treating and preventing infections
#336Methods and compositions for administering an active agent to the pleura of a patient
#337Methods of treating hepatic encephalopathy
#338METHODS OF GENERATING, REPAIRING AND/OR MAINTAINING CONNECTIVE TISSUE IN VIVO
#339Antimicrobial agents and their use in therapy
#340HEPARIN-PEPTIDE BIOCONJUGATES AND USES THEREOF
#341GLYCOPEPTIDE ANTIBIOTIC CONSTRUCTS
#342COMPOSITIONS AND METHODS TO PREVENT AND TREAT BIOFILMS
#343Glycopeptide compositions
#344Cholestosome vesicles for incorporation of molecules into chylomicrons
#345Composition and method for vancomycin oral liquid
#346METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
#347Antibiotic solution and method of injection to prevent ophthalmic infections
#348Substituted urea depsipeptide analogs as activators of the ClpP endopeptidase
#349Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
#350Human genetic markers associated with response to treatments that target clostridium difficile toxin B
#351ADMINISTRATION OF ANTIBIOTIC COMPOUNDS FOR THE TREATMENT OF STREPTOCOCCAL INFECTIONS FOR THE TREATMENT OF PSORIASIS
#352Compositions and methods to prevent and treat biofilms
#353Antibiotic Beads for Treatment of an Infection
#354Glycopeptide derivatives for use in the treatment and/or prevention and/or attenuation of fibrosis diseases
#355Regulate gut microbiota to treat neurodegenerative disorders
#356COMPOSITIONS AND METHODS FOR TREATING BONE AND JOINT INFECTIONS
#357Pharmaceutical compositions containing azaquinone for inhibiting clostridium difficile activity
#358Dry powder Vancomycin compositions and associated methods
#359Prosthetic tissue valves
#360METHOD FOR COATING IMPLANT WITH ACTIVE PHARMACEUTICAL INGREDIENTS
#361Compositions and methods of treating autoimmune disease by reducing enterococcus
#362Anti-MSR1 antibodies and methods of use thereof
#363ANTIBIOTIC FORMULATIONS FOR LOWER BACK PAIN
#364ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS
#365Formulations of vancomycin
#366METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS
#367ANTIBIOTIC THERAPY
#368SMALL CATIONIC ANTI-BIOFILM AND IDR PEPTIDES
#369PHARMACEUTICAL COMPOSITIONS COMPRISING CLOFAZIMINE ANALOG COMPOUND B746 OR CLOFAZIMINE ANALOG COMPOUND B826
#370TREATMENT AND PREVENTION OF CLOSTRIDIUM DIFFICILE COLITIS USING MISOPROSTOL
#371Compositions and methods for treating clostridium difficile infection
#372High purity oritavancin and method of producing same
#373Probiotic recolonisation therapy
#374Compositions and methods for immune cell modulation in adoptive immunotherapies
#375METHODS AND COMPOSITIONS FOR ATTENUATING ANTIBIOTIC RESISTANCE
#376Antimicrobial composition combinations comprising star shaped peptide polymers
#377Fluidic device for the detection, capture, or removal of a disease material
#378COMPOSITIONS FOR RADIOTHERAPY AND USES THEREOF
#379Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
#380Compositions and methods for delivering an agent to a wound
#381Microvascular blood flow decreasing agent and use thereof
#382Methods and devices for bone infection treatment selection
#383SPR741 HUMAN PHARMACOKINETICS AND EFFICACIOUS DOSE
#384Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#385Stabilized glycopeptide antibiotic formulations
#386GENE EDITING FOR IMMUNOLOGICAL DESTRUCTION OF NEOPLASIA
#387Glycopeptide compositions
#388Vancomycin derivative, preparation method, pharmaceutical composition and use thereof
#389Process for encapsulating soluble biologics, therapeutics, and imaging agents
#390Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#391Methods for treating autism spectrum disorder and associated symptoms
#392NOVEL FORMULATION OF PEGYLATED-LIPOSOME ENCAPSULATED GLYCOPEPTIDE ANTIBIOTICS
#393Compositions and methods for treating and preventing infections
#394Anti-infective properties of antifreeze protein
#395Small-molecule adjuvants for antibiotics to address antibiotic resistance
#396Predictive clinical assays and methods of using same
#397Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#398TCO conjugates and methods for delivery of therapeutic agents
#399Chemical structures for localized delivery of therapeutic agents
#400COMBINATION THERAPY COMPRISING OXAZOLIDINONE-QUINOLONES FOR USE IN TREATING BACTERIAL INFECTIONS
#401PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF
#402PHARMACEUTICAL COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
#403Polymyxin B-coated nanoparticles
#404COMPOSITIONS AND METHODS FOR TREATMENT OF SHORT TELOMERE DISORDERS
#405METHOD FOR TREATING NEURODEVELOPMENTAL DISORDERS
#406Technology for the Preparation of Microparticles
#407Substituted urea depsipeptide analogs as activators of the CLPP endopeptidase
#408Use of anti-aging glycoprotein for enhancing survival of neurosensory precursor cells
#409PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#410Medicament for use in treating gout
#411Treatment of clostridium difficile infection
#412Methods for the treatment of myeloid derived suppressor cells related disorders
#413Stabilized vancomycin formulations
#414EXTRACELLULAR MATRIX-BINDING SYNTHETIC PEPTIDOGLYCANS
#415ELP fusion proteins for controlled and sustained release
#416INTRASITE ADMINISTRATION AND DOSING METHODS AND PHARMACEUTICALS FOR USE THEREIN
#417INTRASITE ADMINISTRATION AND DOSING METHODS AND PHARMACEUTICALS FOR USE THEREIN
#418Implantable cellular and biotherapeutic agent delivery canister
#419materials and methods
#420Inhibition and treatment of bacterial infections by sex-specific GPER targeting
#421COMPOSITION AND METHOD FOR TREATING INFECTIONS CAUSED BY VANCOMYCIN-RESISTANT INFECTIOUS AGENTS IN A SUBJECT
#422INTRASITE ADMINISTRATION AND DOSING METHODS AND PHARMACEUTICALS FOR USE THEREIN
#423INTRASITE ADMINISTRATION AND DOSING METHODS AND PHARMACEUTICALS FOR USE THEREIN
#424Pharmaceutical compositions comprising clofazimine analog compound B746 or clofazimine analog compound B826
#425USE OF TEICOPLANIN AGAINST EBOLA VIRUS
#426Drug combination with antitumor effects
#427GLYCOLIPID COMPOUNDS AND THEIR USES IN THE TREATMENT OF TUMOURS
#428Probiotic recolonisation therapy
#429INTRASITE ADMINISTRATION AND DOSING METHODS AND PHARMACEUTICALS FOR USE THEREIN
#430BONE TARGETED THERAPEUTICS AND METHODS OF MAKING AND USING THE SAME
#431Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
#432Conjugated C1 Esterase Inhibitor and Uses Thereof
#433Co-crystals and pharmaceutical compositions comprising the same
#434Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
#435Liposomes containing cell penetrating peptides and tetraetherlipids for the oral delivery of macromolecules
#436BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
#437Methods of treating hepatic encephalopathy
#438Inhibition of multiple pathogenic agents using bithionol
#439Methods and compositions for the treatment of arthritis
#440Treatment of clostridium difficile infection
#441Setting of hardenable bone substitute
#442Methods and devices for bone infection treatment selection
#443Doses and methods for administering telavancin
#444Cell penetrating protein-antibody conjugates and methods of use
#445CCK2R-drug conjugates
#446Interlaced Method for Treating Cancer or a Precancerous Condition
#447METHODS FOR DETECTING AND TREATING LOW-VIRULENCE INFECTIONS
#448Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
#449BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA
#450INTRASITE ADMINISTRATION AND DOSING METHODS AND PHARMACEUTICALS FOR USE THEREIN
#451ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS
#452ANG-(1-7) AND DERIVATIVE OLIGOPEPTIDES FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY AND OTHER COGNITIVE IMPAIRMENTS
#453METHODS OF TREATING COLITIS
#454Prodrugs activated by caspase
#455Use of levocetirizine and montelukast in the treatment of traumatic injury
#456Talc-bound compositions and uses thereof
#457INJECTABLE BONE SUBSTITUTES FOR AUGMENTING IMPLANT FIXATION
#458Antibiotic sensitivity-restoring and photosensitive agents
#459In situ forming hydrogel and method using same
#460Antibacterial products
#461Endolysins Active Against Staphylococcus Bacteria, Pharmaceutical Compositions, and Methods Relating Thereto
#462Glycopeptide compositions
#463Supramolecular gylcosaminoglycans
#464Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#465COMPOSITION OF NOVEL POWDER FORMULATIONS OF TRANEXAMIC ACID
#466Composition and method for vancomycin oral liquid
#467Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#468Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
#469Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#470Method of treating androgen receptor negative prostate tumors and their metastases
#471Enteric combination therapy
#472Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's disease
#473Dosing strategies for targeting EPCAM positive bladder cancer
#474Pharmaceutical compositions containing clofazimine for inhibiting activity
#475METHODS FOR TREATING CLOSTRIDIUM DIFFICILE INFECTION AND ASSOCIATED DISEASE
#476Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#477TREATING CHRONIC RHINOSINUSITIS
#478COMPOSITIONS AND METHODS FOR TREATING MICROBIOTA-RELATED PSYCHOTROPIC CONDITIONS AND DISEASES
#479Cross-platform workload processing
#480ANTIFUNGAL TREATMENT OF PSORIASIS
#481Cholestosome vesicles for incorporation of molecules into chylomicrons
#482Bleomycin-based compositions and use thereof for treating loose skin and fatty tissue
#483ANTIFUNGAL TREATMENT OF ROSACEA
#484ANTIFUNGAL TREATMENT OF CROHN'S DISEASE
#485ANTIFUNGAL TREATMENT OF RHEUMATOID ARTHRITIS
#486Preparation of an oil-in-water emulsion for polymer stabilized pharmaceutical formulations
#487Polysaccharide derivative having membrane-permeable peptide chain
#488Compostions for Treating Dry Eye Disease
#489Medicinal solution to be continuously or pulse-delivered to the eye for treating ophthalmological conditions/maladies
#490Technology for the Preparation of Microparticles
#491WATER-SOLUBLE PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE THERAPEUTICALLY ACTIVE SUBSTANCE AND AT LEAST ONE SUBSTANCE CAPABLE OF FORMING MICELLES
#492Glycopeptides conjugates and uses thereof
#493Cell penetrating antibodies
#494Methods and compositions for inhibiting or preventing adverse effects of oral antibiotics
#495Oral administration of unstable or poorly-absorbed drugs
#496Crystalline isoxazole hydroxamic acid compounds
#497WOUND HEALING COMPOUND
#498Compositions and methods for treating and preventing infections
#499Glycopeptide compositions
#500METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION
#501Implantable cellular and biotherapeutic agent delivery canister
#502Compositions and methods to prevent and treat biofilms
#503Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines
#504Aqueous solution formulations of vancomycin
#505Indication of antibiotic drugs for preparation of cancer inhibition pharmaceutical composition
#506PHARMACEUTICAL FORMULATIONS FOR THE ORAL DELIVERY OF PEPTIDE OR PROTEIN DRUGS
#507NOD2-DEPENDENT PATHWAY OF CYTOPROTECTION OF STEM CELLS
#508Specific Combined Therapy of Malignant Tumors with a Cytostatic and Its Modifier
#509Methods for predicting drug responsiveness
#510COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR WOUND HEALING
#511Methods of treating hepatic encephalopathy
#512Methods and compositions for treating clostridium difficile associated disease
#513Stealth, targeted nanoparticles (STN) for oral drug delivery
#514COMPOSITIONS AND METHODS FOR DELIVERING AN AGENT TO A WOUND
#515Pharmaceutical Compositions for Colon-Specific Delivery
#516INTESTINAL MICROBIOTA AND GVHD
#517PHOSPHOLIPID DEPOT
#518Isolated mucins and different microorganisms, and methods of use
#519Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS
#520ORITAVANCIN FORMULATIONS
#521Positively charged co-polymers for use as antimicrobial agents
#522NOVEL FORMULATION OF PEGYLATED-LIPOSOME ENCAPSULATED GLYCOPEPTIDE ANTIBIOTICS
#523Formulations of vancomycin
#524Method and device for treating microscopic residual tumors remaining in tissues following surgical resection
#525Compositions and methods for delivering an agent to a wound
#526Process for encapsulating soluble biologics, therapeutics, and imaging agents
#527Combined therapy of alpha-1-antitrypsin and temporal T-cell depletion for preventing graft rejection
#528FORMULATIONS OF VANCOMYCIN
#529NOVEL ENTERIC COMBINATION THERAPY
#530Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections
#531ANTIFUNGAL THERAPY FOR THE TREATMENT OF HIRSCHSPRUNG-ASSOCIATED ENTEROCOLITIS
#532COMPOSITION FOR PREVENTING OR TREATING STAPHYLOCOCCUS AUREUS INFECTION
#533BIODEGRADABLE FREE-STANDING CONTROLLED DRUG RELEASE STICKERS
#534METHODS FOR COATING IMPLANT SURFACES TO TREAT SURGICAL INFECTIONS
#535High purity oritavancin and method of producing same
#536METHODS OF GENERATING, REPAIRING AND/OR MAINTAINING CONNECTIVE TISSUE IN VIVO
#537BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES
#538Synergistic clofazimine/metronidazole combination for treating clostridium difficile
#539HEMOSTATIC PHARMACEUTICAL COMPOSITION
#540COMPOSITIONS AND METHODS FOR TREATING BONE AND JOINT INFECTIONS
#541PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#542PHARMACEUTICAL COMPOSITIONS COMPRISING GELS AND METHODS FOR FABRICATING THEREOF
#543Pharmaceutical compositions comprising gels and methods for fabricating thereof
#544Cardiovascular prostheses
#545Cardiovascular Prostheses
#546Cardiovascular Prostheses
#547Antimicrobial articles produced by additive manufacturing
#548TCO conjugates and methods for delivery of therapeutic agents
#549TCO conjugates and methods for delivery of therapeutic agents
#550Anti-vascular disease and antitumor pharmaceutical composition and use thereof
#551Peptide containing conjugates for dual molecular delivery of oligonucleotides
#552Technology for the Preparation of Microparticles
#553Composition and method for vancomycin oral liquid
#554Disc brake arrangement
#555METHODS FOR PRODUCING AN ORALSUSPENSION OF TEICHOPLANIN OR TEICHOPLANIN ANALOGS
#556Use of levocetirizine and montelukast in the treatment of traumatic injury
#557Phospholipid depot
#558SMALL ncRNAS AS BIOMARKERS
#559Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
#560Method and system for producing high purity vancomycin hydrochloride
#561Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
#562Nasal drug delivery and method of making same
#563Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
#564Compositions and methods for treating and preventing infections
#565Glycopeptide derivatives for the preservation and protection of biological materials and microorganisms
#566Pharmaceutical Composition Comprising Stem Cells Treated with NOD2 Agonist or Culture Thereof for Prevention and Treatment of Immune Disorders and Inflammatory Diseases
#567Probiotic recolonisation therapy
#568Probiotic recolonisation therapy
#569Probiotic recolonisation therapy
#570Compositions and methods for treatment of short telomere disorders
#571BISMUTH-THIOLS AS ANTISEPTICS FOR BIOMEDICAL USES, INCLUDING TREATMENT OF BACTERIAL BIOFILMS AND OTHER USES
#572Selective arylation of dichalcogenides in biomolecules
#573Co-crystals and pharmaceutical compositions comprising the same
#574BIOCONJUGATES AND USES THEREOF
#575MEANS AND METHODS FOR INCREASING ANTIBIOTIC ACTIVITY
#576Megalin antagonist
#577Treatment of celiac disease, C. difficile infection, food intolerance and food allergy with secretory IgA/IgM
#578Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's disease
#579Anti-infective properties of antifreeze protein
#580Antibacterial phage, phage peptides and methods of use thereof
#581Antibiotic sensitivity-restoring and photosensitive agents
#582USE OF PEPTIDES IN ANTIBIOTIC RESISTANCE
#583Antimicrobial agents and their use in therapy
#584Probiotic recolonisation therapy
#585Probiotic recolonisation therapy
#586PHARMACEUTICAL OPHTHALMIC COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
#587Composition and method for treatment of ulcers
#588Glycopeptide antibiotic analogs effective against vancomycin-resistant bacterial strains
#589Separation and purification method for vancomycin hydrochloride of high purity
#590Combined application of isothiocyanate compound and anti-cancer medicine
#591DOSES AND METHODS FOR ADMINISTERING TELAVANCIN
#592PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF
#593Compositions for treating dry eye disease
#594Technology for the Preparation of Microparticles
#595MULTI-LAYER CAPSULE AND MANUFACTURE METHOD THEREOF
#596METHODS FOR TREATING BACTEREMIA AND OSTEOMYELITIS USING ORITAVANCIN
#597Methods for treating bacterial infections using oritavancin and polymyxins
#598Vancomycin derivative, and preparation method and application thereof
#599Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
#600Intraocular lens comprising pharmaceutical compositions and methods for fabricating thereof